Michael Hundemer

7PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2026
Harmonizing flow-based quantification of CD19-directed CAR-T cells: Results from a multi-center interlaboratory comparison.

|Nov 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy.

Raphael Lutz, Florian Grünschläger, Malte Simon

|Jun 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities.

Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng

|Mar 09, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.

Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders

|Nov 30, 2021
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.

Stephan M Tirier, Jan-Philipp Mallm, Simon Steiger

|Feb 18, 2021
Selective elimination of immunosuppressive T cells in patients with multiple myeloma.

Mohamed H S Awwad, Abdelrahman Mahmoud, Heiko Bruns

Pageof 2

Frequent Collaborators

5 joint publications

Carsten Müller-Tidow

3 joint publications

Hartmut Goldschmidt

3 joint publications

Mohamed H S Awwad

3 joint publications

Marc S Raab